tiprankstipranks
Coherus Biosciences (CHRS)
NASDAQ:CHRS
Holding CHRS?
Track your performance easily

Coherus Biosciences (CHRS) Technical Analysis

1,392 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Coherus Biosciences’s (CHRS) Moving Averages Convergence Divergence (MACD) indicator is 0.01, suggesting Coherus Biosciences is a Sell.
Coherus Biosciences’s (CHRS) 20-Day exponential moving average is 0.85, while Coherus Biosciences’s (CHRS) share price is $1.08, making it a Buy.
Coherus Biosciences’s (CHRS) 50-Day exponential moving average is 0.95, while Coherus Biosciences’s (CHRS) share price is $1.08, making it a Buy.

Coherus Biosciences (CHRS) Pivot Points

Nov 22, 2024, 04:01 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.58
0.69
0.90
1.01
1.22
1.33
1.54
Fibonacci
0.69
0.82
0.89
1.01
1.14
1.21
1.33
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Coherus Biosciences (CHRS) Moving Averages

Nov 22, 2024, 04:01 PM
Period
Simple
Exponential
MA5
0.91Buy
0.96Buy
MA10
0.85Buy
0.89Buy
MA20
0.79Buy
0.85Buy
MA50
0.91Buy
0.95Buy
MA100
1.18Sell
1.17Sell
MA200
1.66Sell
1.58Sell
Coherus Biosciences’s (CHRS) 10-Day exponential moving average is 0.89, while Coherus Biosciences’s (CHRS) share price is $1.08, making it a Buy.
Coherus Biosciences’s (CHRS) 100-Day exponential moving average is 1.17, while Coherus Biosciences’s (CHRS) share price is $1.08, making it a Sell.
Coherus Biosciences’s (CHRS) stock price is $1.08 and Coherus Biosciences’s (CHRS) 50-day simple moving average is 0.91, creating a Buy signal.
Coherus Biosciences’s (CHRS) stock price is $1.08 and Coherus Biosciences’s (CHRS) 100-day simple moving average is 1.18, creating a Sell signal.
Coherus Biosciences’s (CHRS) stock price is $1.08 and Coherus Biosciences’s (CHRS) 200-day simple moving average is 1.66, creating a Sell signal.

Coherus Biosciences (CHRS) Technical Indicators

Nov 22, 2024, 04:01 PM
Name
Value
Implied Action
RSI (14)
69.15
Neutral
STOCH (9,6)
75.06
Neutral
STOCHRSI (14)
78.04
Neutral
MACD (12,26)
0.01
Sell
ADX (14)
25.43
Neutral
Williams %R
-13.73
Sell
CCI (14)
314.91
Sell
ATR (14)
0.10
-
Ultimate Oscillator
56.34
Neutral
ROC
52.78
Buy
Coherus Biosciences’s (CHRS) Relative Strength Index (RSI) is 69.15, creating a Neutral signal.
Coherus Biosciences’s (CHRS) Trend Strength Indicator (ADX) is 25.43, creating a Neutral signal.
Coherus Biosciences’s (CHRS) Commodity Channel Index (CCI) is 314.91, creating a Sell signal.
Coherus Biosciences’s (CHRS) Price Rate of Change (ROC) is 52.78, creating a Buy signal.

FAQ

Is CHRS a Buy, Hold, or Sell?
Based on CHRS’s technical indicators, CHRS is a Buy.
    What is CHRS’s RSI (14)?
    CHRS’s RSI (14) is 69.15, which suggests CHRS is a Neutral.
      What is CHRS’s MACD?
      CHRS’s MACD is 0.01, which suggests CHRS is a Sell.
        What is CHRS’s 5-day moving average?
        CHRS’s 5-day moving average is 0.91, which suggests CHRS is a Buy.
          What is CHRS’s 20-day moving average?
          CHRS 20-day moving average is 0.79, which suggests CHRS is a Buy.
            What is CHRS’s 50-day moving average?
            CHRS’s 50-day moving average is 0.91, which suggests CHRS is a Buy.
              What is CHRS’s 200-day moving average?
              CHRS’s 200-day moving average is 1.66, which suggests CHRS is a Sell.
                What is CHRS’s Williams % R (14)?
                CHRS’s Williams % R (14) is -13.73, which suggests CHRS is a Sell.
                  What is CHRS’s CCI (14)?
                  CHRS’s CCI (14) is 314.91, which suggests CHRS is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis